Cargando…

Cancer nanomedicine meets immunotherapy: opportunities and challenges

Cancer nanomedicines have shown promise in combination immunotherapy, thus far mostly preclinically but also already in clinical trials. Combining nanomedicines with immunotherapy aims to reinforce the cancer-immunity cycle, via potentiating key steps in the immune reaction cascade, namely antigen r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Qingxue, Bai, Xiangyang, Sofias, Alexandros Marios, van der Meel, Roy, Ruiz-Hernandez, Eduardo, Storm, Gert, Hennink, Wim E., De Geest, Bruno, Kiessling, Fabian, Yu, Hai-jun, Lammers, Twan, Shi, Yang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Singapore 2020
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7470866/ https://www.ncbi.nlm.nih.gov/pubmed/32555445 http://dx.doi.org/10.1038/s41401-020-0448-9

Ejemplares similares

Nanomedicine formulations for combination therapies
por: Lammers, Twan, et al.
Publicado: (2010)

Tumour-targeted nanomedicines: principles and practice
por: Lammers, T, et al.
Publicado: (2008)

The EPR effect and beyond: Strategies to improve tumor targeting and cancer nanomedicine treatment efficacy
por: Shi, Yang, et al.
Publicado: (2020)

Progression of Myeloproliferative Neoplasms (MPN): Diagnostic and Therapeutic Perspectives
por: Baumeister, Julian, et al.
Publicado: (2021)

Nanomedicine and cancer immunotherapy
por: Yu, Hai-jun, et al.
Publicado: (2020)

Image-guided and passively tumour-targeted polymeric nanomedicines for radiochemotherapy
por: Lammers, T, et al.
Publicado: (2008)

Challenges in nanomedicine clinical translation
por: Metselaar, Josbert M., et al.
Publicado: (2020)

Cancer nanomedicine
por: Bhatia, Sangeeta N., et al.
Publicado: (2022)

Spatial heterogeneity of nanomedicine investigated by multiscale imaging of the drug, the nanoparticle and the tumour environment
por: de Maar, Josanne Sophia, et al.
Publicado: (2020)

Multimodal and multiscale optical imaging of nanomedicine delivery across the blood-brain barrier upon sonopermeation
por: May, Jan-Niklas, et al.
Publicado: (2020)

High-resolution 3D visualization of nanomedicine distribution in tumors
por: Moss, Jennifer I., et al.
Publicado: (2020)

A polymeric colchicinoid prodrug with reduced toxicity and improved efficacy for vascular disruption in cancer therapy
por: Crielaard, Bart J, et al.
Publicado: (2011)

Imaging Nanomedicine-Based Drug Delivery: a Review of Clinical Studies
por: Man, Francis, et al.
Publicado: (2018)

Profiling target engagement and cellular uptake of cRGD-decorated clinical-stage core-crosslinked polymeric micelles
por: De Lorenzi, Federica, et al.
Publicado: (2022)

Riboflavin-Targeted Drug Delivery
por: Darguzyte, Milita, et al.
Publicado: (2020)

Imaging-assisted anticancer nanotherapy
por: Dasgupta, Anshuman, et al.
Publicado: (2020)

Sheddable Coatings for Long-Circulating Nanoparticles
por: Romberg, Birgit, et al.
Publicado: (2007)

Nanomedicine Strategies to Target Tumor-Associated Macrophages
por: Binnemars-Postma, Karin, et al.
Publicado: (2017)

Clinical translation of gold nanoparticles
por: Zhang, Rui, et al.
Publicado: (2022)

Shelf-Life Evaluation and Lyophilization of PBCA-Based Polymeric Microbubbles
por: Ojha, Tarun, et al.
Publicado: (2019)

Radiomic analysis of contrast-enhanced ultrasound data
por: Theek, Benjamin, et al.
Publicado: (2018)

When Natural Compounds Meet Nanotechnology: Nature-Inspired Nanomedicines for Cancer Immunotherapy
por: Yu, Linna, et al.
Publicado: (2022)

Activation of cancer immunotherapy by nanomedicine
por: Wang, Lijuan, et al.
Publicado: (2022)

Nanomedicine in Lung Cancer Immunotherapy
por: Doroudian, Mohammad, et al.
Publicado: (2023)

Ultrasound-directed enzyme-prodrug therapy (UDEPT) using self-immolative doxorubicin derivatives
por: Roemhild, Karolin, et al.
Publicado: (2022)

Automated Generation of Reliable Blood Velocity Parameter Maps from Contrast-Enhanced Ultrasound Data
por: Theek, Benjamin, et al.
Publicado: (2017)

Engineered Nanomaterials: The Challenges and Opportunities for Nanomedicines
por: Albalawi, Fahad, et al.
Publicado: (2021)

Opportunities for Nanomedicine in Clostridioides difficile Infection
por: Wang, Pei-Wen, et al.
Publicado: (2021)

Imalytics Preclinical: Interactive Analysis of Biomedical Volume Data
por: Gremse, Felix, et al.
Publicado: (2016)

Engineering Prodrug Nanomedicine for Cancer Immunotherapy
por: Yang, Bin, et al.
Publicado: (2020)

Nanomedicine for Combination Urologic Cancer Immunotherapy
por: Tian, Yun, et al.
Publicado: (2023)

Light-responsive nanomedicine for cancer immunotherapy
por: Kang, Weirong, et al.
Publicado: (2023)

Effect of Liposome Characteristics and Dose on the Pharmacokinetics of Liposomes Coated with Poly(amino acid)s
por: Romberg, Birgit, et al.
Publicado: (2007)

Nanomedicine for ischemic cardiomyopathy: progress, opportunities, and challenges
por: Mahmoudi, Morteza
Publicado: (2020)

Photodynamic and Photothermal Therapies: Synergy Opportunities for Nanomedicine
por: Overchuk, Marta, et al.
Publicado: (2023)

Current Trends and Challenges in the Clinical Translation of Nanoparticulate Nanomedicines: Pathways for Translational Development and Commercialization
por: Hua, Susan, et al.
Publicado: (2018)

Emerging nanomedicines for effective breast cancer immunotherapy
por: Bahreyni, Amirhossein, et al.
Publicado: (2020)

Enhancing Combined Immunotherapy and Radiotherapy through Nanomedicine
por: Hagan, C. Tilden, et al.
Publicado: (2020)

Recent Advancements in Nanomedicine for ‘Cold’ Tumor Immunotherapy
por: Chen, Qinjun, et al.
Publicado: (2021)

Nanomedicine to modulate immunotherapy in cutaneous melanoma (Review)
por: Volovat, Simona Ruxandra, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_9bd2elctkquqttdj9qlpcippsf